The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland · 2026
Clinical effect of Acostream thrombus aspiration device on early acute superior mesenteric artery embolism.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Yaobo, Dong Xuan, Yan Zhaoyong, Jiao Yang, Zhao Yilin, Qu Yichen, Chen Sipan
Аннотация
OBJECTIVE: To investigate the feasibility, safety and efficacy of Acostream thrombus aspiration device in the treatment of early acute superior mesenteric artery embolism.
METHODS: A total of 51 patients with ASEAE in our hospital from May 2020 to May 2025 were enrolled, and their clinical data were retrospectively analyzed. According to different surgical methods, 27 cases were treated with Acostream thrombus aspiration device ((PCDT group), 24 cases were treated with catheter thrombolysis (CDT group). Clinical efficacy and surgical complications were observed and evaluated.
RESULTS: All patients successfully completed the thrombolysis therapy, the technical success rate was 100%. There was no significant difference in basic data between the two groups (P > 0.05), the intervention time and abdominal pain relief time of Acostream group were shorter than those of catheter-thrombolytic group (1.20 ± 0.08 h vs 78.87 ± 13.30 h 、1.26 ± 0.32 h vs 25.00 ± 3.67 h P < 0.05).
CONCLUSION: For acute superior mesenteric artery embolism, the clinical efficacy of Acostream thrombus aspiration is faster and safer than catheter thrombolysis.
METHODS: A total of 51 patients with ASEAE in our hospital from May 2020 to May 2025 were enrolled, and their clinical data were retrospectively analyzed. According to different surgical methods, 27 cases were treated with Acostream thrombus aspiration device ((PCDT group), 24 cases were treated with catheter thrombolysis (CDT group). Clinical efficacy and surgical complications were observed and evaluated.
RESULTS: All patients successfully completed the thrombolysis therapy, the technical success rate was 100%. There was no significant difference in basic data between the two groups (P > 0.05), the intervention time and abdominal pain relief time of Acostream group were shorter than those of catheter-thrombolytic group (1.20 ± 0.08 h vs 78.87 ± 13.30 h 、1.26 ± 0.32 h vs 25.00 ± 3.67 h P < 0.05).
CONCLUSION: For acute superior mesenteric artery embolism, the clinical efficacy of Acostream thrombus aspiration is faster and safer than catheter thrombolysis.